Table 4.
Interaction with NT-proBNP | ||
---|---|---|
noPH-HF | PH-HF | |
Acylcarnitines | ||
free carnitine | NS | NS |
C2-AC | NS | <0.01 |
C16-AC | NS | NS |
C18:1-AC | NS | <0.01 |
C18:2-AC | NS | <0.05 |
Saturated fatty acids | ||
C20:0 | NS | NS |
C22:0 | NS | NS |
C24:0 | NS | NS |
Monounsaturated fatty acids | ||
C16:1Tn7 | NS | NS |
C18:1n7 | NS | <0.01 |
C18:1n9 | NS | <0.01 |
Polyunsaturated fatty acids | ||
C18:2n6 | NS | NS |
C20:4n6 | NS | <0.01 |
C20:5n3 | NS | <0.05 |
C22:4n6 | NS | NS |
C22:5n3 | NS | NS |
C22:6n3 | NS | NS |
When a significant interaction was identified, the correlation between metabolite and NT-proBNP was tested in in both noPH-HF and PF-HF groups. The corresponding p values are shown.